Found 11 matching trials
Study of MK-0663/Etoricoxib in Postorthopedic Knee Replacement Surgery Pain (MK-0663-098) PHASE3 The purpose of this study was to evaluate the efficacy and safety of Etoric...
Show More Location
Multiple Locations
Learn More & Join Trial
Evaluation of the Efficacy, Tolerability and Safety of Etoricoxib (Arcoxia) in Patients With Neuropathic Pain PHASE4 The present study will aim to determine the safety, efficacy, and tolerabil...
Show More Location
MAC (UK) Neruoscience Ltd
Learn More & Join Trial
Use of Etoricoxib Compared to Diclofenac in the Perioperative Treatment of Patients After Total Hip Arthroplasty PHASE3 The primary aim of this study is to test if etoricoxib decreases the periop...
Show More Location
Department of Orthopedic Surgery
Learn More & Join Trial
A Randomized, Double Blind, Placebo-controlled Study to Assess the the Preemptive Benefit of Etoricoxib in Patients Receiving Anterior Cruciate Ligament Reconstruction PHASE4 Post surgical pain associated with ligament reconstruction may persist for ...
Show More Location
National Taiwan University Hospital
Learn More & Join Trial
Safety and Efficacy of an Investigational Drug Versus Placebo in the Treatment of Cancer Pain (0663-083) PHASE2 The purpose of this study is to compare the effectiveness of an investigati...
Show More Location
Multiple Locations
Learn More & Join Trial
A Study of MK0663/Etoricoxib for Post-Abdominal Hysterectomy Surgery Pain (0663-097)(COMPLETED) PHASE3 The purpose of this study is to evaluate the efficacy and safety of etorico...
Show More Location
Multiple Locations
Learn More & Join Trial
A Two-Part, 12-Week Study of Etoricoxib as a Treatment for Rheumatoid Arthritis (RA) (MK-0663-107) PHASE3 This is a 2-part (6 weeks duration for each part), randomized, double-blind...
Show More Location
Multiple Locations
Learn More & Join Trial
Rheumatoid Arthritis Dose Ranging Study (0663-086)(COMPLETED) PHASE2 To assess the clinically active dose range of study medication in the treat...
Show More Location
Multiple Locations
Learn More & Join Trial
A Two-Part 26-Week Study of Etoricoxib as Treatment for Ankylosing Spondylitis (AS) (MK-0663-108) PHASE3 The purpose of the study is to evaluate the efficacy and tolerability of tw...
Show More Location
Multiple Locations
Learn More & Join Trial
Fixed-dose Combination of Etoricoxib + Cyclobenzaprine for Pain Relief After Third Molar Extraction in Brazil PHASE3 Etoricoxib and cyclobenzaprine hydrochloride are active pharmaceutical ingr...
Show More Location
Eurofarma Laboratorios S.A
Learn More & Join Trial